Closing Bell: Hls Therapeutics Inc up on Friday (HLS)

In market activity today, Hls Therapeutics Inc shares closed at $3.35 after opening the day at $3.22. Intraday prices ranged from $3.22 to $3.35.

Shares boosted 6.69% from the previous day's close of $3.14.

Today across North America, the TSX Composite closed -0.15% at 22779.57, the S&P 500 closed 1.11% at 5459.10, the Dow Jones Industrial Average closed 1.64% at 40589.34 and the Nasdaq Composite closed 1.03% at 17357.88.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

A total of 1,500 shares was traded during the last trading day, with total trades of 1, while having an average volume of 97,484 over the last 5-days.

The TSX market on the whole today saw 1,903 price advancers against 3,356 declines and 91 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.30 (August 01,2023) and low as $3.07 (July 24,2024). Moreover, in the last 52 weeks, Hls Therapeutics Inc's shares have shrunken -46.83 percent, while they have dipped -15.19% this year.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $106.58 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Currently, Hls Therapeutics Inc's consensus rating is "Moderate Buy" based on 5 analysts according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..